Global report - October 21, 2016
Pfizer retracts articles by researcher who has left the company
A senior principal scientist for Pfizer, oncology researcher Min-Jean Yin, has departed the company and five cancer research papers in which she had a hand in crafting have since been retracted due to questionable data. This was found by Leonid Schneider, a Germany-based science writer and he posted it on his For Better Science site […]
Global report - October 5, 2016
EU-US collaboration to combat rare diseases
The European Medicines Agency (EMA) and the United States Food and Drug Administration (FDA) have set up a new ‘cluster’ on rare diseases to share experiences and best practices on each other’s regulatory approach to the development of medicines for these diseases. While rare diseases are estimated to affect 30 million people in the European […]
Global report - September 30, 2016
Global leaders gathered to combat antimicrobial resistance
At UN, global leaders commit to act on antimicrobial resistance and make a collective effort to address a challenge to health, food security, and development. For the first time, Heads of State committed to taking a broad, coordinated approach to address the root causes of AMR across multiple sectors, especially human health, animal health and […]
Global report - August 23, 2016
Pfizer to acquire Medivation
Pfizer and Medivation has announced that they have entered into a definitive merger agreement under which Pfizer will acquire Medivation, a biopharmaceutical company focused on developing and commercializing small molecules for oncology, for $81.50 a share in cash for a total enterprise value of approximately $14 billion. The Boards of Directors of both companies have […]
Global report - June 28, 2016
The effects of Brexit
After the Brexit win last week the London-based European Medicines Agency (EMA), which approves medicines for all EU countries, may have to be moved to another country. There is alsi concern that the life science division of Europe’s new Unified Patent Court might have to be moved from London. This is just two of the countless […]
Global report - April 21, 2016
Johannesburg joins Cities Changing Diabetes
The city of Johannesburg joins Novo Nordisk’s Cities Changing Diabetes programme and becomes the first African city to join the global initiative. The addition of the largest city in South Africa as a partner city means Cities Changing Diabetes now brings together six cities across four continents in the fight against urban diabetes. “Diabetes is […]
